Pre-existing biomarkers such as carcinoembryonic antigen (CEA) and carbohydrate antigen (e.g., CA 15–3 and CA19-9) are also frequently used to monitor tumor response, however, their sensitivities and specificities are still controversial for early detection [5,6]. This evidence concerns the gene CEACAM5 and neoplasm.